{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:20Z","timestamp":1786649900336,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>\n                    Typhoid is a major public health concern in India, particularly among those dwelling in urban slums with poor sanitation. The disease caused by\n                    <jats:italic toggle=\"yes\">Salmonella enterica serovar Typhi<\/jats:italic>\n                    spread majorly through contaminated food and water. The economic burden of the disease is catastrophic and affects both families and the government making a strong case for including typhoid vaccines in the national immunization schedule. The World Health Organization has prequalified several vaccines and has recommended their use in endemic areas. While there is robust evidence for vaccination of children from India and other LMICs, the case for adult vaccination remains less clear. The Indian Association of Preventive and Social Medicine acknowledges the necessity to adopt a widespread typhoid immunization program, along with other preventive strategies, especially in the vulnerable pockets. IAPSM recommends focusing on newer-generation Typhoid Conjugate Vaccines (TCVs), which provide long-lasting and superior immunological benefits, and are effective across all ages including adults. IAPSM suggests routine use of Typbar-TCV\u2122 for adults up to 45 years old in India. The organization also highlights the necessity for post-marketing surveillance of these vaccines, to monitor the long-term safety and effectiveness of various vaccines in different communities. IAPSM encourages members to take front-line efforts in their community health service areas, and finally appeals for the development of vaccines to cover a more extensive range of Salmonella infections so that control over typhoid can be strengthened.\n                  <\/jats:p>","DOI":"10.4103\/ijcm.ijcm_740_24","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T07:00:39Z","timestamp":1735542039000},"page":"S139-S145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["IAPSM\u2019s Position Paper on Typhoid Vaccines for Adult Immunization in India"],"prefix":"10.4103","volume":"49","author":[{"given":"Kapil","family":"Goel","sequence":"first","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, All India Institute of Medical Sciences, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swayam Pragyan","family":"Parida","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr B R Ambedkar State Institute of Medical Sciences, Mohali, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Nadda","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr B R Ambedkar State Institute of Medical Sciences, Mohali, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr B R Ambedkar State Institute of Medical Sciences, Mohali, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"John","sequence":"additional","affiliation":[{"name":"Department of Community Health and Development, Christian Medical Collegeand Hospital, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"Suppl 1","key":"R1-20260423","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: A call for coordinated action","volume":"62","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R2-20260423","first-page":"855.","article-title":"Typhoid fever surveillance and vaccine use \u2014 South-East Asia and Western Pacific regions, 2009\u20132013","volume":"63","author":"Date","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 \u2013 Recommendations","volume":"37","author":"Organization","year":"2019","journal-title":"Vaccine"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"369.","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: A systematic analysis for the Global Burden of Disease Study 2017","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"e0008048.","DOI":"10.1371\/journal.pntd.0008048","article-title":"Changes in historical typhoid transmission across 16 U.S. cities, 1889\u20131931: Quantifying the impact of investments in water and sewer infrastructures","volume":"14","author":"Phillips","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 5","key":"R7-20260423","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1093\/cid\/ciz610","article-title":"Water and filth: Reevaluating the first era of sanitary typhoid intervention (1840\u20131940)","volume":"69","author":"Vanderslott","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"e0004616.","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: Systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"1491.","DOI":"10.1056\/NEJMoa2209449","article-title":"Burden of typhoid and paratyphoid fever in India","volume":"388","author":"John","year":"2023","journal-title":"N Engl J Med"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"e85867.","DOI":"10.7554\/eLife.85867","article-title":"Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes","volume":"12","author":"Carey","year":"2023","journal-title":"Elife"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"289.","DOI":"10.1186\/1471-2458-7-289","article-title":"Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India","volume":"7","author":"Sur","year":"2007","journal-title":"BMC Public Health"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"115.","DOI":"10.1186\/1471-2458-9-115","article-title":"A typhoid fever outbreak in a slum of South Dumdum municipality, West Bengal, India, 2007: Evidence for foodborne and waterborne transmission","volume":"9","author":"Bhunia","year":"2009","journal-title":"BMC Public Health"},{"key":"R14-20260423","first-page":"875","article-title":"IAP Task Force Report: Diagnosis of enteric fever in children","volume":"43","author":"Kundu","year":"2006","journal-title":"Indian Pediatr"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/JCM.39.4.1571-1576.2001","article-title":"Quantitation of bacteria in bone marrow from patients with typhoid fever: Relationship between counts and clinical features","volume":"39","author":"Wain","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R16-20260423","first-page":"CD008892","article-title":"Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever","volume":"5","author":"Wijedoru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"MBio"},{"issue":"Suppl 5","key":"R18-20260423","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiab282","article-title":"Cost of illness due to severe enteric fever in India","volume":"224","author":"Kumar","year":"2021","journal-title":"J Infect Dis"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the VI capsular polysaccharide of salmonella typhi","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: A randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"1685.","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal c polysaccharide vaccine in toddlers","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide\u2013tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: A multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7 years following primary vaccination of children","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13312-021-2096-7","article-title":"Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended immunization schedule (2020\u201321) and update on immunization for children aged 0 through 18 years","volume":"58","author":"Kasi","year":"2021","journal-title":"Indian Pediatr"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyphTM) in Indian children: School based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R28-20260423","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2015\/13302.5903","article-title":"A study on longevity of immune response after vaccination with salmonella typhi Vi Conjugate Vaccine (PedatyphTM) in children","author":"Chinnasami","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13312-022-2520-7","article-title":"Long-term persistence of immunogenicity after primary vaccination and response to booster vaccination with typhoid conjugate vaccine: Results of a phase IV extension study","volume":"59","author":"Kandulna","year":"2022","journal-title":"Indian Pediatr"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CVI.00791-13","article-title":"Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India","volume":"21","author":"Ochiai","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A Cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"R33-20260423","first-page":"2023","article-title":"Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)","author":"Gloeck","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"22.","DOI":"10.4103\/ijmr.IJMR_1890_17","article-title":"The need and the issues related to new-generation typhoid conjugate vaccines in India","volume":"151","author":"Vashishtha","year":"2020","journal-title":"Indian J Med Res"},{"key":"R35-20260423","first-page":"20","article-title":"A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: A phase II preliminary report","author":"Medise","year":"2020","journal-title":"BMC Pediatr"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.vaccine.2019.09.074","article-title":"Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report","volume":"38","author":"Capeding","year":"2020","journal-title":"Vaccine"},{"key":"R40-20260423","first-page":"357","article-title":"Guidelines for vaccination in normal adults in India","volume":"25","author":"Enderle","year":"1970","journal-title":"Indian J Nephrol Acta Cardiol"},{"key":"R42-20260423","doi-asserted-by":"crossref","first-page":"e0277419.","DOI":"10.1371\/journal.pone.0277419","article-title":"Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study","volume":"17","author":"Limani","year":"2022","journal-title":"PLoS One"},{"key":"R43-20260423","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: A modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R44-20260423","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/j.vaccine.2021.06.003","article-title":"Cost effectiveness of typhoid vaccination in India","volume":"39","author":"Chauhan","year":"2021","journal-title":"Vaccine"},{"key":"R45-20260423","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"key":"R46-20260423","first-page":"711","article-title":"Evaluating investments in typhoid vaccines in two slums in Kolkata, India","volume":"27","author":"Cook","year":"2010","journal-title":"J Heal Popul Nutr"},{"issue":"Suppl 2","key":"R47-20260423","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1093\/cid\/ciaa597","article-title":"Decision making and implementation of the first public sector introduction of typhoid conjugate vaccine\u2014Navi Mumbai, India, 2018","volume":"71","author":"Date","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R48-20260423","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/ijmr.IJMR_411_18","article-title":"Typhoid fever: Control and challenges in India","volume":"150","author":"Mukhopadhyay","year":"2019","journal-title":"Indian J Med Res"},{"key":"R49-20260423","first-page":"37","article-title":"Barriers to typhoid fever vaccine access in endemic countries","volume":"8","author":"Khan","year":"2017","journal-title":"Res Rep Trop Med"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_740_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:39Z","timestamp":1786647579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_740_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_740_24","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-10-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}